Clinical Trials Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Financials
Clinical Data Issues Results for Fiscal First Quarter and Updates Strategic Initiatives
August 27th, 2007
Clinical Data, Inc. (NASDAQ: CLDA) reported consolidated financial results for the Company's fiscal first quarter ended June 30, 2007. Revenue for the fiscal first quarter declined $3.6 million to $14.0 million, compared with the same period a year ago. The decrease was due to (i) the expected absence of one-time revenue items recognized in 2006 totaling $2.1 million related to Icoria's discontinued agriculture business, (ii) a $1.0 million decline in OEM sales within the Company's European IVD business, and (iii) a focus on internal laboratory projects associated with biomarker discovery and sequencing for the recently completed Phase III pivotal clinical trial of...
Source: Clinical Trials Week (2007-08-27)
|
